Paul Sweeney

2.6k total citations
65 papers, 1.9k citations indexed

About

Paul Sweeney is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Paul Sweeney has authored 65 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 20 papers in Molecular Biology and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Paul Sweeney's work include Cancer, Hypoxia, and Metabolism (11 papers), Renal cell carcinoma treatment (7 papers) and Angiogenesis and VEGF in Cancer (7 papers). Paul Sweeney is often cited by papers focused on Cancer, Hypoxia, and Metabolism (11 papers), Renal cell carcinoma treatment (7 papers) and Angiogenesis and VEGF in Cancer (7 papers). Paul Sweeney collaborates with scholars based in Ireland, United States and United Kingdom. Paul Sweeney's co-authors include Colin P. Dinney, Joel W. Slaton, Takashi Karashima, Keiji Inoue, David J. McConkey, Louis L. Pisters, Paul Perrotte, Daniel J. Hicklin, Daniel Kedar and Randall E. Millikan and has published in prestigious journals such as Journal of the American College of Cardiology, Kidney International and The Journal of Urology.

In The Last Decade

Paul Sweeney

62 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Sweeney Ireland 24 744 560 529 528 353 65 1.9k
Takashi Saika Japan 27 845 1.1× 558 1.0× 681 1.3× 431 0.8× 152 0.4× 125 2.1k
Stephen B. Leapman United States 18 973 1.3× 502 0.9× 448 0.8× 485 0.9× 524 1.5× 49 2.5k
Osamu Ishiko Japan 25 537 0.7× 384 0.7× 209 0.4× 335 0.6× 242 0.7× 174 2.4k
Kenkichi Koiso Japan 22 451 0.6× 743 1.3× 483 0.9× 421 0.8× 183 0.5× 129 1.8k
Cynthia C. Daugherty United States 20 772 1.0× 456 0.8× 586 1.1× 279 0.5× 803 2.3× 41 2.8k
Deepak M. Sahasrabudhe United States 21 376 0.5× 532 0.9× 281 0.5× 580 1.1× 103 0.3× 67 1.5k
Yoav H. Messinger United States 32 844 1.1× 1.7k 3.0× 1.2k 2.3× 359 0.7× 289 0.8× 106 3.5k
Peter Shamamian United States 29 542 0.7× 649 1.2× 417 0.8× 740 1.4× 346 1.0× 68 2.2k
William B. Coman Australia 28 695 0.9× 719 1.3× 424 0.8× 632 1.2× 364 1.0× 56 2.4k
Janice M. Lage United States 39 622 0.8× 728 1.3× 496 0.9× 394 0.7× 223 0.6× 98 3.5k

Countries citing papers authored by Paul Sweeney

Since Specialization
Citations

This map shows the geographic impact of Paul Sweeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Sweeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Sweeney more than expected).

Fields of papers citing papers by Paul Sweeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Sweeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Sweeney. The network helps show where Paul Sweeney may publish in the future.

Co-authorship network of co-authors of Paul Sweeney

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Sweeney. A scholar is included among the top collaborators of Paul Sweeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Sweeney. Paul Sweeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sweeney, Paul, et al.. (2025). Objective Markers for Diagnosing Concussions: Beyond Blood Biomarkers and the Role of Real-Time Diagnostic Tools. Journal of Clinical Medicine. 14(21). 7727–7727. 1 indexed citations
2.
3.
4.
Sweeney, Paul, et al.. (2020). Screening for Obstructive Sleep Apnea in an Atrial Fibrillation Population: What’s the Best Test?. CJC Open. 3(4). 442–449. 9 indexed citations
5.
Sweeney, Paul, Cormac D. Murphy, & Patrick Caffrey. (2015). Exploiting the genome sequence of Streptomyces nodosus for enhanced antibiotic production. Applied Microbiology and Biotechnology. 100(3). 1285–1295. 21 indexed citations
6.
Davis, Niall F., et al.. (2015). A novel rapid access testicular cancer clinic: prospective evaluation after one year. Irish Journal of Medical Science (1971 -). 185(1). 215–218. 2 indexed citations
7.
Davis, Niall F., Margaret Fitzgerald, John P. Burke, et al.. (2014). Is there a role for the development of a supra-regional network for the management of penile cancer in the Republic of Ireland?. The Surgeon. 14(2). 82–86. 5 indexed citations
8.
Ahmad, Sarfraz, et al.. (2012). DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?. PubMed. 10(1). 9–9. 9 indexed citations
9.
O’Donovan, Tracey R., Sarfraz Ahmad, Chris Collins, et al.. (2011). VHL genetic alteration in CCRCC does not determine de-regulation of HIF, CAIX, hnRNP A2/B1 and osteopontin. PubMed. 34(3). 225–234. 14 indexed citations
10.
Connolly, Sheelah, et al.. (2010). Impact of pharmacotherapy on the incidence of transurethral prostatectomy for benign prostatic hyperplasia and the implications for surgical training.. PubMed. 103(9). 281–2. 2 indexed citations
11.
Sweeney, Paul, et al.. (2010). Urine Cytology in the Evaluation of Urological Malignancy Revisited: Is It Still Necessary?. Urologia Internationalis. 84(1). 45–49. 10 indexed citations
12.
Rogers, Eamonn, et al.. (2007). Renal artery embolisation in the palliative treatment of renal carcinoma. British Journal of Radiology. 80(950). 96–102. 42 indexed citations
13.
Mohamedali, Khalid A., Daniel Kedar, Paul Sweeney, et al.. (2005). The Vascular-Targeting Fusion Toxin VEGF121/rGel Inhibits the Growth of Orthotopic Human Bladder Carcinoma Tumors. Neoplasia. 7(10). 912–920. 30 indexed citations
14.
Connolly, Stephen S., et al.. (2004). Can computed tomography in the protocol for renal colic be interpreted by urologists?. British Journal of Urology. 94(9). 1332–1335. 9 indexed citations
15.
Sweeney, Paul, Christopher G. Wood, Louis L. Pisters, et al.. (2003). Surgical management of renal cell carcinoma associated with complex inferior vena caval thrombi. Urologic Oncology Seminars and Original Investigations. 21(5). 327–333. 73 indexed citations
16.
Slaton, Joel W., Takashi Karashima, Paul Perrotte, et al.. (2001). Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.. PubMed. 7(9). 2840–53. 50 indexed citations
17.
Sweeney, Paul, Leonie S. Young, & J. M. Fitzpatrick. (2001). An autoradiographic study of regional blood flow distribution in the rat kidney during ureteric obstruction— the role of vasoactive compounds. British Journal of Urology. 88(3). 268–272. 9 indexed citations
18.
Hegarty, Nicholas J., Leonie S. Young, Caitriona Kirwan, et al.. (2001). Nitric oxide in unilateral ureteral obstruction: Effect on regional renal blood flow. Kidney International. 59(3). 1059–1065. 53 indexed citations
19.
Sweeney, Paul & Louis L. Pisters. (2000). Ad5CMVp53 gene therapy for locally advanced prostate cancer - where do we stand?. World Journal of Urology. 18(2). 121–124. 24 indexed citations
20.
Neumann, Veronica, Tom Blanchard, Paul Sweeney, et al.. (1999). Effective induction of HIV-specific CTL by multi-epitope using gene gun in a combined vaccination regime. Vaccine. 17(6). 589–596. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takashi Saika Breakdown of academic impact, for papers by Stephen B. Leapman Breakdown of academic impact, for papers by Osamu Ishiko Breakdown of academic impact, for papers by Kenkichi Koiso Breakdown of academic impact, for papers by Cynthia C. Daugherty Breakdown of academic impact, for papers by Deepak M. Sahasrabudhe Breakdown of academic impact, for papers by Yoav H. Messinger Breakdown of academic impact, for papers by Peter Shamamian Breakdown of academic impact, for papers by William B. Coman Breakdown of academic impact, for papers by Janice M. Lage
Rankless by CCL
2026